Author:
Dannecker G.,Hospach T.,Kümmerle-Deschner J.,Benseler S.,Kallinich T.,Keitzer R.,Frosch M.,Roth J.
Publisher
Springer Berlin Heidelberg
Reference292 articles.
1. Athappan G, Gale S, Ponniah T (2009) Corticosteroid therapy for primary treatment of Kawasaki disease – weight of evidence: a metaanalysis and systematic review of the literature. Cardiovascular Journal of Africa 20: 233–236
2. Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, Klein N, Booy R, Levin M, Dillon MJ (2002) Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 86: 286–290
3. Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, Melish ME, Jackson MA, Asmar BI, Lang DJ, Connor JD, Capparelli EV, Keen ML, Mamun K, Keenan GF, Ramilo O (2008) Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 153: 833–838
4. Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364: 533–544
5. Chang RK (2002) Hospitalizations for Kawasaki disease among children in the United States, 1988–1997. Pediatrics 109: e87